Adaptive Biotechnologies Price Target Announced at $35.00/Share by Goldman Sachs
Ratings actions from Benzinga
Related stories
Trump Expected To Fly Qatar-Gifted Air Force One To Asia — NBC
Questions Remain About Aircraft Upgrades
L impact | NEWS | Nov 15, 2026, 11:17 PM UTC
VP Vance May Wait Until Late Spring To Reveal 2028 Plans — Axios
L impact | NEWS | Nov 15, 2026, 11:17 PM UTC
Asian Stocks Brace For AI Pressure, Data Dump
L impact | NEWS | Nov 15, 2026, 10:56 PM UTC
ICYMI | EU Banking Watchdog Working On Alternative Ways To Tackle Lending Risk — FT
L impact | NEWS | Nov 15, 2026, 10:47 PM UTC
Beijing Sinotau International Pharmaceutical Technology: highest bid price in global offering HK$68 per H share
L impact | NEWS | Nov 15, 2026, 10:33 PM UTC
US Now Has Three Carrier Strike Groups In CENTCOM Area After USS Roosevelt Arrives — Axios
L impact | NEWS | Nov 15, 2026, 10:29 PM UTC